This isn't the first time Mylan CEO Heather Bresch has been under fire.
Bresch, who started out in a low-level position in quality control at one of the company's factories, is the first female head of a large pharmaceutical company. She made a name for herself by turning the EpiPen — once an obscure injection device for allergy sufferers that she calls her "baby" -- in...
Also read: Roku Expects IPO to Raise More Than $200 Million
Read more
